nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP1A1—Dacarbazine—pancreatic cancer	0.0745	0.0989	CbGbCtD
Ticlopidine—CYP1A1—Tamoxifen—pancreatic cancer	0.0593	0.0786	CbGbCtD
Ticlopidine—CYP2E1—Dacarbazine—pancreatic cancer	0.0576	0.0764	CbGbCtD
Ticlopidine—CYP1A1—Erlotinib—pancreatic cancer	0.0504	0.0669	CbGbCtD
Ticlopidine—CYP2E1—Tamoxifen—pancreatic cancer	0.0458	0.0607	CbGbCtD
Ticlopidine—CYP2B6—Tamoxifen—pancreatic cancer	0.0452	0.0599	CbGbCtD
Ticlopidine—MPO—superior mesenteric artery—pancreatic cancer	0.0412	0.838	CbGeAlD
Ticlopidine—CYP2B6—Irinotecan—pancreatic cancer	0.0347	0.046	CbGbCtD
Ticlopidine—CYP2C8—Tamoxifen—pancreatic cancer	0.0342	0.0454	CbGbCtD
Ticlopidine—CYP1A2—Dacarbazine—pancreatic cancer	0.0333	0.0442	CbGbCtD
Ticlopidine—CYP2C8—Erlotinib—pancreatic cancer	0.0291	0.0386	CbGbCtD
Ticlopidine—CYP2C19—Tamoxifen—pancreatic cancer	0.0287	0.0381	CbGbCtD
Ticlopidine—CYP1A2—Tamoxifen—pancreatic cancer	0.0265	0.0351	CbGbCtD
Ticlopidine—CYP2C8—Fluorouracil—pancreatic cancer	0.0252	0.0334	CbGbCtD
Ticlopidine—CYP2C9—Tamoxifen—pancreatic cancer	0.0239	0.0317	CbGbCtD
Ticlopidine—CYP1A2—Erlotinib—pancreatic cancer	0.0225	0.0299	CbGbCtD
Ticlopidine—CYP2D6—Tamoxifen—pancreatic cancer	0.0218	0.0289	CbGbCtD
Ticlopidine—CYP1A2—Fluorouracil—pancreatic cancer	0.0195	0.0259	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—pancreatic cancer	0.0189	0.0251	CbGbCtD
Ticlopidine—CYP2D6—Erlotinib—pancreatic cancer	0.0186	0.0246	CbGbCtD
Ticlopidine—CYP2C9—Fluorouracil—pancreatic cancer	0.0176	0.0233	CbGbCtD
Ticlopidine—CYP3A4—Tamoxifen—pancreatic cancer	0.0139	0.0184	CbGbCtD
Ticlopidine—CYP3A4—Erlotinib—pancreatic cancer	0.0118	0.0157	CbGbCtD
Ticlopidine—CYP3A4—Irinotecan—pancreatic cancer	0.0107	0.0141	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—pancreatic cancer	0.00915	0.0121	CbGbCtD
Ticlopidine—CYP3A4—Docetaxel—pancreatic cancer	0.00781	0.0104	CbGbCtD
Ticlopidine—CYP3A4—Sunitinib—pancreatic cancer	0.00777	0.0103	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—pancreatic cancer	0.00582	0.00772	CbGbCtD
Ticlopidine—MPO—pancreas—pancreatic cancer	0.00149	0.0303	CbGeAlD
Ticlopidine—MPO—digestive system—pancreatic cancer	0.00127	0.0259	CbGeAlD
Ticlopidine—CYP2C19—digestive system—pancreatic cancer	0.000852	0.0173	CbGeAlD
Ticlopidine—CYP1A2—digestive system—pancreatic cancer	0.000696	0.0142	CbGeAlD
Ticlopidine—CYP1A1—digestive system—pancreatic cancer	0.000686	0.014	CbGeAlD
Ticlopidine—CYP2B6—digestive system—pancreatic cancer	0.000667	0.0136	CbGeAlD
Ticlopidine—CYP2C9—digestive system—pancreatic cancer	0.00066	0.0134	CbGeAlD
Ticlopidine—CYP2E1—digestive system—pancreatic cancer	0.000626	0.0127	CbGeAlD
Ticlopidine—CYP3A4—digestive system—pancreatic cancer	0.000504	0.0102	CbGeAlD
Ticlopidine—CYP2D6—digestive system—pancreatic cancer	0.000496	0.0101	CbGeAlD
Ticlopidine—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000489	0.00287	CcSEcCtD
Ticlopidine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000482	0.00283	CcSEcCtD
Ticlopidine—Haemoglobin—Gemcitabine—pancreatic cancer	0.000479	0.00281	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.000478	0.00281	CcSEcCtD
Ticlopidine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000477	0.0028	CcSEcCtD
Ticlopidine—Haemorrhage—Gemcitabine—pancreatic cancer	0.000477	0.0028	CcSEcCtD
Ticlopidine—Angioedema—Sunitinib—pancreatic cancer	0.000472	0.00277	CcSEcCtD
Ticlopidine—Haemoglobin—Fluorouracil—pancreatic cancer	0.000471	0.00276	CcSEcCtD
Ticlopidine—Anorexia—Tamoxifen—pancreatic cancer	0.00047	0.00276	CcSEcCtD
Ticlopidine—Haemorrhage—Fluorouracil—pancreatic cancer	0.000469	0.00275	CcSEcCtD
Ticlopidine—Anorexia—Erlotinib—pancreatic cancer	0.000465	0.00273	CcSEcCtD
Ticlopidine—Arthropathy—Doxorubicin—pancreatic cancer	0.000462	0.00271	CcSEcCtD
Ticlopidine—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000451	0.00265	CcSEcCtD
Ticlopidine—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000451	0.00265	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000449	0.00264	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000444	0.00261	CcSEcCtD
Ticlopidine—Cramp muscle—Docetaxel—pancreatic cancer	0.00044	0.00258	CcSEcCtD
Ticlopidine—Arthralgia—Sunitinib—pancreatic cancer	0.00044	0.00258	CcSEcCtD
Ticlopidine—Myalgia—Sunitinib—pancreatic cancer	0.00044	0.00258	CcSEcCtD
Ticlopidine—Colitis—Epirubicin—pancreatic cancer	0.000436	0.00256	CcSEcCtD
Ticlopidine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000434	0.00255	CcSEcCtD
Ticlopidine—Dyspepsia—Erlotinib—pancreatic cancer	0.000429	0.00252	CcSEcCtD
Ticlopidine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000428	0.00251	CcSEcCtD
Ticlopidine—Decreased appetite—Erlotinib—pancreatic cancer	0.000424	0.00249	CcSEcCtD
Ticlopidine—Pain—Tamoxifen—pancreatic cancer	0.000421	0.00247	CcSEcCtD
Ticlopidine—Flatulence—Irinotecan—pancreatic cancer	0.00042	0.00246	CcSEcCtD
Ticlopidine—Pain—Erlotinib—pancreatic cancer	0.000417	0.00245	CcSEcCtD
Ticlopidine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000413	0.00243	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—pancreatic cancer	0.000411	0.00241	CcSEcCtD
Ticlopidine—Muscle spasms—Irinotecan—pancreatic cancer	0.000409	0.0024	CcSEcCtD
Ticlopidine—Colitis—Doxorubicin—pancreatic cancer	0.000404	0.00237	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000403	0.00237	CcSEcCtD
Ticlopidine—Anorexia—Sunitinib—pancreatic cancer	0.000402	0.00236	CcSEcCtD
Ticlopidine—Pancytopenia—Docetaxel—pancreatic cancer	0.000401	0.00236	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000399	0.00234	CcSEcCtD
Ticlopidine—Sepsis—Epirubicin—pancreatic cancer	0.000394	0.00231	CcSEcCtD
Ticlopidine—Urticaria—Tamoxifen—pancreatic cancer	0.000391	0.0023	CcSEcCtD
Ticlopidine—Body temperature increased—Erlotinib—pancreatic cancer	0.000385	0.00226	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000384	0.00226	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—pancreatic cancer	0.00038	0.00223	CcSEcCtD
Ticlopidine—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000379	0.00223	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000373	0.00219	CcSEcCtD
Ticlopidine—Dyspepsia—Sunitinib—pancreatic cancer	0.000371	0.00218	CcSEcCtD
Ticlopidine—Renal failure—Docetaxel—pancreatic cancer	0.00037	0.00217	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000369	0.00217	CcSEcCtD
Ticlopidine—Vascular purpura—Epirubicin—pancreatic cancer	0.000369	0.00216	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—pancreatic cancer	0.000367	0.00215	CcSEcCtD
Ticlopidine—Decreased appetite—Sunitinib—pancreatic cancer	0.000367	0.00215	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—pancreatic cancer	0.000365	0.00214	CcSEcCtD
Ticlopidine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000363	0.00213	CcSEcCtD
Ticlopidine—Pain—Sunitinib—pancreatic cancer	0.000361	0.00212	CcSEcCtD
Ticlopidine—Epistaxis—Docetaxel—pancreatic cancer	0.000355	0.00209	CcSEcCtD
Ticlopidine—Asthenia—Tamoxifen—pancreatic cancer	0.000353	0.00208	CcSEcCtD
Ticlopidine—Arthralgia—Gemcitabine—pancreatic cancer	0.000353	0.00207	CcSEcCtD
Ticlopidine—Myalgia—Gemcitabine—pancreatic cancer	0.000353	0.00207	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000351	0.00206	CcSEcCtD
Ticlopidine—Asthenia—Erlotinib—pancreatic cancer	0.00035	0.00205	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000349	0.00205	CcSEcCtD
Ticlopidine—Pruritus—Tamoxifen—pancreatic cancer	0.000349	0.00205	CcSEcCtD
Ticlopidine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000348	0.00204	CcSEcCtD
Ticlopidine—Myalgia—Fluorouracil—pancreatic cancer	0.000347	0.00204	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000345	0.00203	CcSEcCtD
Ticlopidine—Pruritus—Erlotinib—pancreatic cancer	0.000345	0.00202	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—pancreatic cancer	0.000342	0.00201	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—pancreatic cancer	0.000341	0.002	CcSEcCtD
Ticlopidine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00034	0.002	CcSEcCtD
Ticlopidine—Haemoglobin—Docetaxel—pancreatic cancer	0.00034	0.002	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—pancreatic cancer	0.000339	0.00199	CcSEcCtD
Ticlopidine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000339	0.00199	CcSEcCtD
Ticlopidine—Haemorrhage—Docetaxel—pancreatic cancer	0.000338	0.00199	CcSEcCtD
Ticlopidine—Hepatitis—Docetaxel—pancreatic cancer	0.000338	0.00199	CcSEcCtD
Ticlopidine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000337	0.00198	CcSEcCtD
Ticlopidine—Body temperature increased—Sunitinib—pancreatic cancer	0.000334	0.00196	CcSEcCtD
Ticlopidine—Diarrhoea—Erlotinib—pancreatic cancer	0.000334	0.00196	CcSEcCtD
Ticlopidine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000333	0.00195	CcSEcCtD
Ticlopidine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000332	0.00195	CcSEcCtD
Ticlopidine—Anorexia—Irinotecan—pancreatic cancer	0.000331	0.00195	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—pancreatic cancer	0.000331	0.00194	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—pancreatic cancer	0.00033	0.00194	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.00033	0.00194	CcSEcCtD
Ticlopidine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000326	0.00191	CcSEcCtD
Ticlopidine—Dizziness—Tamoxifen—pancreatic cancer	0.000326	0.00191	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000323	0.0019	CcSEcCtD
Ticlopidine—Anorexia—Gemcitabine—pancreatic cancer	0.000323	0.00189	CcSEcCtD
Ticlopidine—Dizziness—Erlotinib—pancreatic cancer	0.000322	0.00189	CcSEcCtD
Ticlopidine—Erythema multiforme—Docetaxel—pancreatic cancer	0.00032	0.00188	CcSEcCtD
Ticlopidine—Anorexia—Fluorouracil—pancreatic cancer	0.000317	0.00186	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—pancreatic cancer	0.000317	0.00186	CcSEcCtD
Ticlopidine—Vomiting—Tamoxifen—pancreatic cancer	0.000313	0.00184	CcSEcCtD
Ticlopidine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000311	0.00183	CcSEcCtD
Ticlopidine—Rash—Tamoxifen—pancreatic cancer	0.000311	0.00182	CcSEcCtD
Ticlopidine—Dermatitis—Tamoxifen—pancreatic cancer	0.00031	0.00182	CcSEcCtD
Ticlopidine—Vomiting—Erlotinib—pancreatic cancer	0.00031	0.00182	CcSEcCtD
Ticlopidine—Headache—Tamoxifen—pancreatic cancer	0.000309	0.00181	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000308	0.00181	CcSEcCtD
Ticlopidine—Rash—Erlotinib—pancreatic cancer	0.000307	0.0018	CcSEcCtD
Ticlopidine—Dermatitis—Erlotinib—pancreatic cancer	0.000307	0.0018	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000306	0.0018	CcSEcCtD
Ticlopidine—Dyspepsia—Irinotecan—pancreatic cancer	0.000306	0.0018	CcSEcCtD
Ticlopidine—Headache—Erlotinib—pancreatic cancer	0.000305	0.00179	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000305	0.00179	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000305	0.00179	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000304	0.00179	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000303	0.00178	CcSEcCtD
Ticlopidine—Asthenia—Sunitinib—pancreatic cancer	0.000303	0.00178	CcSEcCtD
Ticlopidine—Decreased appetite—Irinotecan—pancreatic cancer	0.000302	0.00177	CcSEcCtD
Ticlopidine—Pruritus—Sunitinib—pancreatic cancer	0.000299	0.00175	CcSEcCtD
Ticlopidine—Pain—Irinotecan—pancreatic cancer	0.000297	0.00175	CcSEcCtD
Ticlopidine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000294	0.00173	CcSEcCtD
Ticlopidine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000293	0.00172	CcSEcCtD
Ticlopidine—Nausea—Tamoxifen—pancreatic cancer	0.000293	0.00172	CcSEcCtD
Ticlopidine—Pain—Gemcitabine—pancreatic cancer	0.00029	0.0017	CcSEcCtD
Ticlopidine—Nausea—Erlotinib—pancreatic cancer	0.00029	0.0017	CcSEcCtD
Ticlopidine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000289	0.0017	CcSEcCtD
Ticlopidine—Diarrhoea—Sunitinib—pancreatic cancer	0.000289	0.00169	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—pancreatic cancer	0.000287	0.00168	CcSEcCtD
Ticlopidine—Pain—Fluorouracil—pancreatic cancer	0.000285	0.00167	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000284	0.00167	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—pancreatic cancer	0.000283	0.00166	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—pancreatic cancer	0.000282	0.00166	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000282	0.00165	CcSEcCtD
Ticlopidine—Dizziness—Sunitinib—pancreatic cancer	0.000279	0.00164	CcSEcCtD
Ticlopidine—Body temperature increased—Irinotecan—pancreatic cancer	0.000275	0.00161	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—pancreatic cancer	0.000271	0.00159	CcSEcCtD
Ticlopidine—Vomiting—Sunitinib—pancreatic cancer	0.000268	0.00158	CcSEcCtD
Ticlopidine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000268	0.00157	CcSEcCtD
Ticlopidine—Rash—Sunitinib—pancreatic cancer	0.000266	0.00156	CcSEcCtD
Ticlopidine—Dermatitis—Sunitinib—pancreatic cancer	0.000266	0.00156	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—pancreatic cancer	0.000265	0.00156	CcSEcCtD
Ticlopidine—Urticaria—Fluorouracil—pancreatic cancer	0.000264	0.00155	CcSEcCtD
Ticlopidine—Headache—Sunitinib—pancreatic cancer	0.000264	0.00155	CcSEcCtD
Ticlopidine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000263	0.00154	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000261	0.00153	CcSEcCtD
Ticlopidine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000256	0.0015	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000252	0.00148	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—pancreatic cancer	0.000251	0.00147	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—pancreatic cancer	0.000251	0.00147	CcSEcCtD
Ticlopidine—Nausea—Sunitinib—pancreatic cancer	0.000251	0.00147	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—pancreatic cancer	0.00025	0.00147	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—pancreatic cancer	0.00025	0.00147	CcSEcCtD
Ticlopidine—Asthenia—Irinotecan—pancreatic cancer	0.000249	0.00146	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000249	0.00146	CcSEcCtD
Ticlopidine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000245	0.00144	CcSEcCtD
Ticlopidine—Asthenia—Gemcitabine—pancreatic cancer	0.000243	0.00143	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—pancreatic cancer	0.000242	0.00142	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00024	0.00141	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—pancreatic cancer	0.00024	0.00141	CcSEcCtD
Ticlopidine—Pruritus—Gemcitabine—pancreatic cancer	0.00024	0.00141	CcSEcCtD
Ticlopidine—Diarrhoea—Irinotecan—pancreatic cancer	0.000238	0.0014	CcSEcCtD
Ticlopidine—Pruritus—Fluorouracil—pancreatic cancer	0.000236	0.00138	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000235	0.00138	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000233	0.00137	CcSEcCtD
Ticlopidine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000232	0.00136	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—pancreatic cancer	0.000231	0.00136	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00023	0.00135	CcSEcCtD
Ticlopidine—Dizziness—Irinotecan—pancreatic cancer	0.00023	0.00135	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—pancreatic cancer	0.000229	0.00135	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—pancreatic cancer	0.000229	0.00134	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—pancreatic cancer	0.000228	0.00134	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—pancreatic cancer	0.000228	0.00134	CcSEcCtD
Ticlopidine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000228	0.00134	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—pancreatic cancer	0.000224	0.00132	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—pancreatic cancer	0.000222	0.0013	CcSEcCtD
Ticlopidine—Vomiting—Irinotecan—pancreatic cancer	0.000221	0.0013	CcSEcCtD
Ticlopidine—Dizziness—Fluorouracil—pancreatic cancer	0.00022	0.00129	CcSEcCtD
Ticlopidine—Rash—Irinotecan—pancreatic cancer	0.000219	0.00129	CcSEcCtD
Ticlopidine—Dermatitis—Irinotecan—pancreatic cancer	0.000219	0.00129	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000219	0.00129	CcSEcCtD
Ticlopidine—Headache—Irinotecan—pancreatic cancer	0.000218	0.00128	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000216	0.00127	CcSEcCtD
Ticlopidine—Vomiting—Gemcitabine—pancreatic cancer	0.000215	0.00126	CcSEcCtD
Ticlopidine—Rash—Gemcitabine—pancreatic cancer	0.000213	0.00125	CcSEcCtD
Ticlopidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000213	0.00125	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—pancreatic cancer	0.000213	0.00125	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000212	0.00125	CcSEcCtD
Ticlopidine—Headache—Gemcitabine—pancreatic cancer	0.000212	0.00125	CcSEcCtD
Ticlopidine—Vomiting—Fluorouracil—pancreatic cancer	0.000212	0.00124	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—pancreatic cancer	0.000212	0.00124	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—pancreatic cancer	0.000211	0.00124	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000211	0.00124	CcSEcCtD
Ticlopidine—Rash—Fluorouracil—pancreatic cancer	0.00021	0.00123	CcSEcCtD
Ticlopidine—Dermatitis—Fluorouracil—pancreatic cancer	0.00021	0.00123	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—pancreatic cancer	0.000209	0.00123	CcSEcCtD
Ticlopidine—Headache—Fluorouracil—pancreatic cancer	0.000209	0.00122	CcSEcCtD
Ticlopidine—Nausea—Irinotecan—pancreatic cancer	0.000206	0.00121	CcSEcCtD
Ticlopidine—Pain—Docetaxel—pancreatic cancer	0.000205	0.00121	CcSEcCtD
Ticlopidine—Nausea—Gemcitabine—pancreatic cancer	0.000201	0.00118	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.0002	0.00117	CcSEcCtD
Ticlopidine—Nausea—Fluorouracil—pancreatic cancer	0.000198	0.00116	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—pancreatic cancer	0.000197	0.00116	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000196	0.00115	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—pancreatic cancer	0.000196	0.00115	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—pancreatic cancer	0.000191	0.00112	CcSEcCtD
Ticlopidine—Body temperature increased—Docetaxel—pancreatic cancer	0.00019	0.00112	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—pancreatic cancer	0.000181	0.00106	CcSEcCtD
Ticlopidine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000177	0.00104	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000177	0.00104	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—pancreatic cancer	0.000172	0.00101	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—pancreatic cancer	0.00017	0.000998	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—pancreatic cancer	0.000169	0.000993	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—pancreatic cancer	0.000169	0.000993	CcSEcCtD
Ticlopidine—Diarrhoea—Docetaxel—pancreatic cancer	0.000164	0.000965	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000162	0.000951	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—pancreatic cancer	0.000159	0.000933	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000159	0.000932	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—pancreatic cancer	0.000156	0.000918	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—pancreatic cancer	0.000156	0.000918	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—pancreatic cancer	0.000154	0.000907	CcSEcCtD
Ticlopidine—Vomiting—Docetaxel—pancreatic cancer	0.000153	0.000897	CcSEcCtD
Ticlopidine—Rash—Docetaxel—pancreatic cancer	0.000151	0.000889	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—pancreatic cancer	0.000151	0.000889	CcSEcCtD
Ticlopidine—Headache—Docetaxel—pancreatic cancer	0.000151	0.000884	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00015	0.00088	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000148	0.000867	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000147	0.000862	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—pancreatic cancer	0.000143	0.000839	CcSEcCtD
Ticlopidine—Nausea—Docetaxel—pancreatic cancer	0.000143	0.000838	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—pancreatic cancer	0.000143	0.000838	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—pancreatic cancer	0.000141	0.000827	CcSEcCtD
Ticlopidine—Pain—Epirubicin—pancreatic cancer	0.000139	0.000814	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000137	0.000802	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000133	0.000778	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000132	0.000775	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—pancreatic cancer	0.00013	0.000765	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—pancreatic cancer	0.000129	0.000756	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—pancreatic cancer	0.000128	0.000753	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—pancreatic cancer	0.000128	0.000752	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000123	0.00072	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000119	0.000701	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—pancreatic cancer	0.000119	0.000699	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000119	0.000696	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—pancreatic cancer	0.000116	0.000683	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—pancreatic cancer	0.000115	0.000673	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—pancreatic cancer	0.000111	0.000651	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00011	0.000649	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—pancreatic cancer	0.000108	0.000632	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—pancreatic cancer	0.000107	0.000629	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—pancreatic cancer	0.000106	0.000623	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—pancreatic cancer	0.000103	0.000605	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000103	0.000602	CcSEcCtD
Ticlopidine—Rash—Epirubicin—pancreatic cancer	0.000102	0.0006	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—pancreatic cancer	0.000102	0.000599	CcSEcCtD
Ticlopidine—Headache—Epirubicin—pancreatic cancer	0.000102	0.000596	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—pancreatic cancer	9.92e-05	0.000582	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—pancreatic cancer	9.63e-05	0.000565	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—pancreatic cancer	9.53e-05	0.00056	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—pancreatic cancer	9.45e-05	0.000555	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—pancreatic cancer	9.45e-05	0.000555	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—pancreatic cancer	9.39e-05	0.000552	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—pancreatic cancer	8.91e-05	0.000523	CcSEcCtD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CB—pancreatic cancer	2.01e-05	0.00075	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PRSS1—pancreatic cancer	2.01e-05	0.000749	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—HRAS—pancreatic cancer	1.97e-05	0.000737	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCL8—pancreatic cancer	1.93e-05	0.00072	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ARG2—pancreatic cancer	1.88e-05	0.000703	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ARG2—pancreatic cancer	1.85e-05	0.000689	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.84e-05	0.000686	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TERT—pancreatic cancer	1.84e-05	0.000686	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HIF1A—pancreatic cancer	1.76e-05	0.000656	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TSC2—pancreatic cancer	1.75e-05	0.000654	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—AKT1—pancreatic cancer	1.74e-05	0.00065	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ARG2—pancreatic cancer	1.74e-05	0.000649	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—APOE—pancreatic cancer	1.72e-05	0.00064	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KDR—pancreatic cancer	1.68e-05	0.000627	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TYMP—pancreatic cancer	1.65e-05	0.000614	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.64e-05	0.000613	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TYMP—pancreatic cancer	1.61e-05	0.000602	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NFKBIA—pancreatic cancer	1.6e-05	0.000597	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.6e-05	0.000595	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NOTCH1—pancreatic cancer	1.58e-05	0.000591	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CG—pancreatic cancer	1.55e-05	0.000578	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—NRAS—pancreatic cancer	1.55e-05	0.000578	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGF—pancreatic cancer	1.53e-05	0.000571	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TYMP—pancreatic cancer	1.52e-05	0.000567	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.51e-05	0.000564	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.5e-05	0.000559	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.42e-05	0.000531	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—EGFR—pancreatic cancer	1.41e-05	0.000527	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.39e-05	0.00052	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CD—pancreatic cancer	1.36e-05	0.000508	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.35e-05	0.000503	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—KRAS—pancreatic cancer	1.33e-05	0.000497	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GLP1R—pancreatic cancer	1.33e-05	0.000495	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.31e-05	0.000489	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—DPYD—pancreatic cancer	1.31e-05	0.000487	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GLP1R—pancreatic cancer	1.3e-05	0.000485	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.3e-05	0.000484	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.28e-05	0.000477	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—DPYD—pancreatic cancer	1.28e-05	0.000477	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.25e-05	0.000468	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.24e-05	0.000464	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	1.24e-05	0.000462	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.23e-05	0.000457	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CA—pancreatic cancer	1.22e-05	0.000457	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	1.21e-05	0.000453	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.21e-05	0.00045	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CB—pancreatic cancer	1.19e-05	0.000443	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.15e-05	0.000429	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.14e-05	0.000427	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.14e-05	0.000427	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL8—pancreatic cancer	1.14e-05	0.000426	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.13e-05	0.000423	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HRAS—pancreatic cancer	1.13e-05	0.000423	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.13e-05	0.000423	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.12e-05	0.000419	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.11e-05	0.000414	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.11e-05	0.000413	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—AKT1—pancreatic cancer	1.1e-05	0.000411	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.09e-05	0.000408	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CASP3—pancreatic cancer	1.09e-05	0.000407	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCND1—pancreatic cancer	1.06e-05	0.000396	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CTNNB1—pancreatic cancer	1.05e-05	0.000393	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.05e-05	0.000391	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.04e-05	0.000387	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MMP9—pancreatic cancer	1.03e-05	0.000385	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.03e-05	0.000383	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTEN—pancreatic cancer	1.03e-05	0.000383	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1e-05	0.000374	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1e-05	0.000374	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—AKT1—pancreatic cancer	1e-05	0.000373	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.96e-06	0.000371	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.88e-06	0.000368	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—DPYD—pancreatic cancer	9.87e-06	0.000368	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMP—pancreatic cancer	9.7e-06	0.000362	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CD44—pancreatic cancer	9.6e-06	0.000358	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SRC—pancreatic cancer	9.51e-06	0.000355	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CD44—pancreatic cancer	9.4e-06	0.000351	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	9.37e-06	0.000349	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.36e-06	0.000349	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.27e-06	0.000346	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—pancreatic cancer	9.26e-06	0.000346	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.23e-06	0.000344	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GCG—pancreatic cancer	9.2e-06	0.000343	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—pancreatic cancer	9.17e-06	0.000342	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NRAS—pancreatic cancer	9.15e-06	0.000341	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	9.15e-06	0.000341	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.13e-06	0.000341	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—DPYD—pancreatic cancer	9.08e-06	0.000339	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GCG—pancreatic cancer	9.01e-06	0.000336	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—DPYD—pancreatic cancer	9e-06	0.000336	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.95e-06	0.000334	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CD44—pancreatic cancer	8.86e-06	0.000331	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.68e-06	0.000324	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—STK11—pancreatic cancer	8.65e-06	0.000323	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	8.61e-06	0.000321	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.6e-06	0.000321	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ARG2—pancreatic cancer	8.56e-06	0.000319	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	8.54e-06	0.000319	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—pancreatic cancer	8.52e-06	0.000318	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TGFB1—pancreatic cancer	8.5e-06	0.000317	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GCG—pancreatic cancer	8.5e-06	0.000317	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—STK11—pancreatic cancer	8.47e-06	0.000316	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.45e-06	0.000315	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—pancreatic cancer	8.34e-06	0.000311	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.16e-06	0.000304	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.15e-06	0.000304	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CD44—pancreatic cancer	8.13e-06	0.000303	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8e-06	0.000299	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—STK11—pancreatic cancer	7.99e-06	0.000298	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.96e-06	0.000297	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.88e-06	0.000294	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—pancreatic cancer	7.88e-06	0.000294	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	7.82e-06	0.000292	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GCG—pancreatic cancer	7.79e-06	0.000291	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—DPYD—pancreatic cancer	7.69e-06	0.000287	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.5e-06	0.00028	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMP—pancreatic cancer	7.48e-06	0.000279	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TYMS—pancreatic cancer	7.44e-06	0.000278	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.43e-06	0.000277	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—STK11—pancreatic cancer	7.32e-06	0.000273	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	7.3e-06	0.000272	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TYMS—pancreatic cancer	7.29e-06	0.000272	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CD44—pancreatic cancer	7.25e-06	0.000271	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—pancreatic cancer	7.24e-06	0.00027	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.22e-06	0.000269	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.1e-06	0.000265	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.04e-06	0.000263	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—pancreatic cancer	7e-06	0.000261	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.97e-06	0.00026	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GCG—pancreatic cancer	6.95e-06	0.000259	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.88e-06	0.000257	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TYMS—pancreatic cancer	6.87e-06	0.000256	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—pancreatic cancer	6.69e-06	0.00025	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CD44—pancreatic cancer	6.67e-06	0.000249	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CD44—pancreatic cancer	6.61e-06	0.000247	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—STK11—pancreatic cancer	6.54e-06	0.000244	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.48e-06	0.000242	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.42e-06	0.000239	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GCG—pancreatic cancer	6.4e-06	0.000239	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.35e-06	0.000237	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GCG—pancreatic cancer	6.34e-06	0.000237	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.3e-06	0.000235	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.14e-06	0.000229	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—APOE—pancreatic cancer	6.05e-06	0.000226	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.03e-06	0.000225	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—STK11—pancreatic cancer	6.01e-06	0.000224	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—STK11—pancreatic cancer	5.96e-06	0.000222	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.93e-06	0.000221	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—APOE—pancreatic cancer	5.93e-06	0.000221	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—pancreatic cancer	5.91e-06	0.000221	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CD44—pancreatic cancer	5.65e-06	0.000211	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.63e-06	0.00021	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMS—pancreatic cancer	5.62e-06	0.00021	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.6e-06	0.000209	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—APOE—pancreatic cancer	5.59e-06	0.000209	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.53e-06	0.000206	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.48e-06	0.000205	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	5.46e-06	0.000204	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GCG—pancreatic cancer	5.42e-06	0.000202	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	5.35e-06	0.0002	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.29e-06	0.000197	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARG—pancreatic cancer	5.27e-06	0.000197	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.17e-06	0.000193	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARG—pancreatic cancer	5.16e-06	0.000193	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.13e-06	0.000191	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—APOE—pancreatic cancer	5.12e-06	0.000191	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—STK11—pancreatic cancer	5.09e-06	0.00019	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	5.04e-06	0.000188	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARG—pancreatic cancer	4.87e-06	0.000182	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.85e-06	0.000181	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	4.8e-06	0.000179	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.78e-06	0.000178	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	4.7e-06	0.000175	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.62e-06	0.000173	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—APOE—pancreatic cancer	4.57e-06	0.000171	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.46e-06	0.000167	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.43e-06	0.000165	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.38e-06	0.000163	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CD44—pancreatic cancer	4.36e-06	0.000163	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.33e-06	0.000162	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—APOE—pancreatic cancer	4.21e-06	0.000157	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	4.19e-06	0.000156	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GCG—pancreatic cancer	4.18e-06	0.000156	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—APOE—pancreatic cancer	4.17e-06	0.000156	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	4.15e-06	0.000155	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.13e-06	0.000154	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	4.1e-06	0.000153	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.07e-06	0.000152	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	4.06e-06	0.000152	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.98e-06	0.000149	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.95e-06	0.000147	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—STK11—pancreatic cancer	3.93e-06	0.000147	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.87e-06	0.000144	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.83e-06	0.000143	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.8e-06	0.000142	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.76e-06	0.00014	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.66e-06	0.000137	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.63e-06	0.000136	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.63e-06	0.000135	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.62e-06	0.000135	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—APOE—pancreatic cancer	3.56e-06	0.000133	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.54e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.54e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.51e-06	0.000131	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.38e-06	0.000126	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.37e-06	0.000126	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.34e-06	0.000125	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.34e-06	0.000125	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.31e-06	0.000123	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.22e-06	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.16e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.13e-06	0.000117	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.1e-06	0.000116	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.06e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.91e-06	0.000109	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.88e-06	0.000108	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.88e-06	0.000108	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.86e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.83e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—APOE—pancreatic cancer	2.75e-06	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.73e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.55e-06	9.52e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.51e-06	9.38e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.5e-06	9.32e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.49e-06	9.3e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.48e-06	9.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.46e-06	9.19e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.44e-06	9.11e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.4e-06	8.94e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.36e-06	8.79e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.18e-06	8.14e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	8.06e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.13e-06	7.95e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—pancreatic cancer	2.08e-06	7.78e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.04e-06	7.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	7.19e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.92e-06	7.18e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.9e-06	7.1e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.88e-06	7.03e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.77e-06	6.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.76e-06	6.58e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.76e-06	6.56e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.64e-06	6.13e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.58e-06	5.88e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.5e-06	5.61e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.45e-06	5.41e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.44e-06	5.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.23e-06	4.58e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.16e-06	4.33e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—pancreatic cancer	9.47e-07	3.53e-05	CbGpPWpGaD
